Human rights and HIV prevention, treatment, and care for people who inject drugs: Key principles and research needs

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue SUPPL. 1, 2010, Pages

  Wolfe, Daniel ^a   Cohen, Jonathan ^a  

^a OPEN SOCIETY FOUNDATIONS   (United States)

Author keywords

Antiretroviral; Buprenorphine; Drug dependence; Human rights; Methadone; Police; Prison; Substance abuse

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BUPRENORPHINE; METHADONE;

CONDOM; DRUG DETOXIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SAFE SEX; SEXUAL BEHAVIOR; SOCIAL STATUS; UNSAFE SEX; VIRUS TRANSMISSION; WITHDRAWAL SYNDROME;

HIV INFECTIONS; HUMAN RIGHTS; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 78449290480     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181f9c0de     Document Type: Review

References (95)

1. Wolfe D, Sempruch MK. Seeing double: mapping contradictions in HIV prevention and illicit drug policy worldwide. In: Beyrer C, Pizer H, eds. Public Health and Human Rights: Evidence-Based Approaches. Baltimore, MD: Johns Hopkins University Press; 2007:330-361.
2. Csete J, Cohen J. Lethal violations: human rights abuses faced by injection drug users in the era of HIV/AIDS. In: Malinowska Sempruch K, Gallagher S, eds. War on Drugs, HIV/AIDS and Human Rights. New York, NY: International Debate Education Assocation; 2004:212-227.
3. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733-1745.
4. Institute of Medicine. Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence. Washington, DC: National Academies Press; 2007.
5. Herget G. Methadone and buprenorphine added to the WHO list of essential medicines. HIV AIDS Policy Law Rev. 2005;10:23-24.
6. Mocroft A, Madge S, Johnson AM, et al. A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immune Defic Syndr. 1999;22:369-378.
7. Wood E, Hogg RS, Yip B, et al. Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. AIDS. 2005;19:1189-1195.
8. World Health Organization. HIV/AIDS treatment and care: clinical protocol for Injecting Drug Users. HIV/AIDS treatment and care: Clinical protocol for the WHO European Region. Copenhagen, Denmark: WHO EURO; 2006.
9. Carrieri MP, Spire B. Harm reduction and control of HIV in IDUs in France. Lancet. 2008;372:448.
10. Program Coordinating Board. Report of the Twenty-Fourth Meeting of the Programme Coordinating Board. Geneva, Switzerland: UNAIDS; 2009.
11. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
12. Wolfe D. Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. Int J Drug Policy. 2007;18:246-254.
13. Donoghoe MC, Bollerup AR, Lazarus JV, et al. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004. Int J Drug Policy. 2007;18:271-280.
14. Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151: 241-251, W-252.
15. Sharma M, Oppenheimer E, Saidel T, et al. A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region. AIDS. 2009;23:1405-1413.
16. Ball AL. Universal access to HIV/AIDS treatment for injecting drug users: keeping the promise. Int J Drug Policy. 2007;18:241-245.
17. Harm Reduction Developments 2005: Countries with Injection Driven Epidemics. New York, NY: International Harm Reduction Development Program, Open Society Institute; 2006.
18. Struthers M, Csete J. Fanning the Flames: How Human Rights Abuses are Fueling the AIDS Epidemics in Kazakhstan. New York, NY: Human Rights Watch; 2003.
19. Wolfe D, Saucier R. AtWhat Cost? HIVand Human Rights Consequences of the Global "War on Drugs". New York, NY: Open Society Institute; 2009.
20. Wolfe D, Saucier R. In Rehabilitation's name: ending institutionalised cruelty and degrading treatment of people who use drugs. Int J Drug Policy. 2010;21:145-260.
21. Csete J, Cohen J. Human rights in Vancouver: do injection drug users have a friend in city hall? Can HIV AIDS Policy Law Rev. 2003;8:1, 7-10.
22. Human RightsWatch. Injecting Reason: Human Rights and HIV Prevention for Injecting Drug Users. New York, NY: Human Rights Watch; 2003.
23. Schleifer R. Rhetoric and Risk: Human Rights Abuses Impeding Ukraine's Fight Against HIV/AIDS. Human Rights Watch. 2006;18(2):1-88.
24. Maru V. Ravaging the Vulnerable: Abuses Against Persons at High Risk of HIV Infection in Bangladesh. Vol. 15. New York: Human RightsWatch; 2003:6(C).
25. Human Rights Watch. Lessons Not Learned: Human Rights Abuses and HIV/AIDS in the Russian Federation. New York, NY: Human Rights Watch; 2004.
26. Davis SL, Triwahyuono A, Alexander R. Survey of abuses against injecting drug users in Indonesia. Harm Reduct J. 2009;6:28.
27. Hammett TM, Wu Z, Duc TT, et al. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction. 2008;103:137-145.
28. Umar S. Break you down to build you up: the Malaysian experience. Paper presented at: 20th Conference on the Reduction of Drug-Related Harm; April 2009; Bangkok, Thailand.
29. Rhodes T, Singer M, Bourgois P, et al. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005;61:1026-1044.
30. Krusi A, Wood E, Montaner J, et al. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Policy. 2010;21:4-9.
31. Strathdee SA, Patrick DM, Archibald CP, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 1997;92:1339-1347.
32. Burris S, Blankenship KM, Donoghoe M, et al. Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop. Milbank Q. 2004;82:125-156.
33. Strathdee S, Hallett T, Bobrova N, et al. HIV and the risk environment among people who inject drugs: past, present, and projections for the future. Lancet. 2010; In Press.
34. Hayashi K, Milloy M, Fairbairn N, et al. Incarceration experiences among a community - recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health. 2009;9:492.
35. Fairbairn N, Hayashi K, Kaplan K, et al. Evidence Planting by Thai Police Violates the Human Rights of People who Inject Drugs. BMC International Health and Human Rights: Vancouver/Bangkok; 2009.
36. Sarang A, Rhodes T, Sheon N, et al. Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse. 2010;45:813-864.
37. Werb D, Kerr T, Small W, et al. HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies. J Public Health (Oxf). 2008;30:126-132.
38. Epperson M. A longitudinal study of incarceration and HIV risk among methadone maintained men and their primary female partners. AIDS Behav. 2010. DOI: 10.1007/s10461-009-9660-9.
39. Trostle J. Medical compliance as an ideology. Soc Sci Med. 1988;27: 1299-1308.
40. Escaffre N, Morin M, Bouhnik AD, et al. Injecting drug users' adherence to HIVantiretroviral treatments: physicians' beliefs. AIDS Care. 2000;12: 723-730.
41. Barriers to Access: Medication-Assisted Treatment and Injection-Driven HIV Epidemics. New York, NY: International Harm Reduction Development Program, Open Society Institute; 2008.
42. Rhodes T, Platt L, Sarang A, et al. Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives. J Urban Health. 2006;83:911-925.
43. Shields A. The Effects of Drug User Registration Laws on People's Rights and Health: Key Findings From Russia, Georgia, and Ukraine. International Harm Reduction Development Program, Open Society Institute; 2009.
44. Sarang A, Stuikyte R, Bykov R. Implementation of harm reduction in Central and Eastern Europe and Central Asia. Int J Drug Policy. 2007;18: 129-135.
45. Bobrova N, Sarang A, Stuikyte R, et al. Obstacles in provision of antiretroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview. Int J Drug Policy. 2007;18:313-318.
46. Wolfe D, Carrieri P, Shepard D, et al. Treatment and care for HIV-infected injecting drug users: a review of barriers and way forward. Lancet. 2010; 376:355-366.
47. Martin JP. 25+ Human Rights Documents. New York, NY: Columbia University Center for the Study of Human Rights; 2001.
48. International Harm Reduction Association and Human Rights Watch. Recalibrating the Regime: The Need for a Human Rights-Based Approach to International Drug Policy. London, United Kingdom: International Harm Reduction Association and Human Rights Watch; 2008.
49. Cohen J, Wolfe D. Harm reduction and human rights: finding common cause. AIDS. 2008;22(Suppl 2):S93-S94.
50. Csete J, Elliott R, Kerr T, et al. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy. Health Hum Rights. 2005;8:104-138.
51. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 28:47-58.
52. Newman C. Establishing and maintaining a therapeutic alliance with substance abuse patients: a cognitve therapy approach. In: Lisa Simon Onken, Jack D. Blaine, John J. Boren. Beyond the Therapeutic Alliance: Keeping the Drug-Dependent Individual in Treatment. Rockville, MD: National Institute on Drug Abuse; 1994.
53. Shannon K, Rusch M, Shoveller J, et al. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. Int J Drug Policy. 2008;19:140-147.
54. Werb D, Wood E, Small W, et al. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy. 2008;19:332-338.
55. Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003;57:39-54.
56. Bobrova N, Rhodes T, Power R, et al. Barriers to accessing drug treatment in Russia: a qualitative study among injecting drug users in two cities. Drug Alcohol Depend. 2006;82(Suppl 1):S57-S63.
57. Csete J, Elliott R. Scaling up HIV testing: human rights and hidden costs. HIV/AIDS Policy and Law Rev. 2006;11:5-10.
58. Jürgens R. Increasing access to HIV testing and counselling while respecting human rights. The Law and Health Initiative, Open Society Institute. 2007; 12(2/3):1-130.
59. Patrick S, Forman S. Multilateralism and US Foreign Policy: Ambivalent Engagement. London, United Kingdom: Lynne Rienner Publishers; 2002.
60. Neier A. Social and economic rights: a critique. Hum Rts Brief. 2006; 13(2):1-3.
61. Alston P, Robinson M. Human Rights and Development: Towards Mutual Reinforcement. New York, NY: New York University Center for Human Rights; 2005.
62. Altice F, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 28:47-58.
63. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20:85-92.
64. Kahn J. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health. 1996;86:1709.
65. WHO, UNODC, UNAIDS. Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users. Geneva, Switzerland: World Health Organization; 2009.
66. World Health Organization. WHO Framework for Global Monitoring and Reporting: Monitoring and Reporting on the Health Sector's Response Towards Universal Access to HIV/AIDS Treatment, Prevention, Care and Support, 2009-2010. Geneva, Switzerland: WHO; 2009.
67. Rhodes T. The risk environment': a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13:85-94.
68. Cohen J, Csete J. Not enough graves: the war on drugs, HIV/AIDS, and violations of human rights. Human Rights Watch. 2004;16(8):1-60.
69. Ainsworth M, Beyrer C, Soucat A. AIDS and public policy: the lessons and challenges of "success" in Thailand. Health Policy. 2003; 64:13-37.
70. Sarang A, Rhodes T, Platt L, et al. Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: qualitative study. Addiction. 2006;101:1787-1796.
71. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health. 2002;92:1789-1794.
72. Beyrer C, Jittiwutikarn J, Teokul W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav. 2003;7:153-161.
73. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
74. Hartocollis A. City Urged to Withdraw Flier on Safer Heroin Use That Some See as How-To Guide. The New York Times. A17. January 4, 2010. Available at: http://www.nytimes.com/2010/01/06/nyregion/06needles.html. Accessed January 6, 2010.
75. United Nations General Assembly. International Covenant on Economic, Social, and Cultural Rights res 2200a (XXI). New York, NY: United Nations; December 16, 1966.
76. Walmsley R. World Prison Population List. London, United Kingdom: International Centre for Prison Studies (ICPS); 2007.
77. Nowak M. Report of the Special Rapporteur on Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment. United Nations. Document no. A/HRC/10/44; Geneva, Switzerland: 2009.
78. United Nations General Assembly. International Covenant on Civil and Political Rights Res 2200A (XXI). New York, NY: United Nations; 1966.
79. Lines R. The right to health of prisoners in international human rights law. Int J Prisoner Health. 2008;4:3-53.
80. Khudobin V. Russia. 59696/00. Strasbourg, France: The European Court of Human Rights (Third Section); 2007.
81. Yakovenko V. Ukraine. 15825/06. Strasbourg, France: The European Court of Human Rights (Fifth Section); 2008.
82. Ghavtadze V. Georgia. 23204/07. Strasbourg, France: The European Court of Human Rights (Second Section); 2009.
83. Standard Minimum Rules for the Treatment of Prisoners. Res. 663 C (XXIV): UN ECOSOC; Geneva, Switzerland. July 1957.
84. The Global Campaign for Pretrial Justice. Pretrial Detention and Public Health: Unintended Consequences, Deadly Results. New York, NY: Open Society Institute; 2010.
85. Epstein H. Claiming the Right to Health. Lancet. 2005;366:1155.
86. Jurgens R, Csete J, Amon J. Human rights and effects on HIV prevention and treatment (TBD). Lancet. 2010;376:475-485.
87. Costa A. Keynote address. Presented at: 19th International Conference on the Reduction of Drug Related Harm; Warsaw, Poland; May 11, 2008.
88. Pillay N. High Commissioner Calls for Focus on Human Rights and Harm Reduction in International Drug Policy. Geneva Switzerland: United Nations Press Release; March 10, 2009.
89. Carey C, Tolopilo A. Tipping the Balance: Why Legal Services Are Essential to Health Care for Drug Users in Ukraine. New York: Open Society Institute, Public Health Program; 2008.
90. Ki Moon B. Progress made in the implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS. Paper presented at: United Nations General Assembly; 2008; New York, NY.
91. O'Hara M. Curb AIDS and HIV by decriminalising drugs, say experts. The Observer. April 19, 2009.
92. Hughes C, Stevens A. Briefing Paper Fourteen: The Effects of Decriminalization of Drug Use in Portugal Publisher: The Beckley Foundation Drug Policy Programme; 2007. pp. 1-10.
93. UNAIDS. Addressing Human Rights Issues in National Responses to HIV: A Review of Programmes to Reduce Stigma and Discrimination and Increase Access to Justice. Geneva, Switzerland: United Nations; 2009.
94. Piot P, Bartos M, Larson H, et al. Coming to terms with complexity: a call to action for HIV prevention. Lancet. 2008;372:845-859.
95. Merson M, O'Malley J, Serwadda D, et al. The history and challenge of HIV prevention. Lancet. 2008;372:475-488.